UpSite Clinical
David Rodin is a seasoned executive with extensive experience in clinical research and pharmaceutical development. As the Co-Founder and CEO of Upsite Clinical since August 2023, David also serves as Co-Chair of the BioNJ Clinical Development Committee and has been a Project Team Member with the Clinical Trials Transformation Initiative since 2008. Previously, David held key positions such as Senior Vice President of Patient Recruitment and Client Engagement at IMA Clinical Research, where significant contributions included establishing a central patient recruitment group and screening over 8,000 patients for a major Alzheimer’s program. As CEO of Amici Clinical Research from 2017 to 2022, David led the development of two clinical research sites and successfully negotiated the company’s sale to IMA. With a background that includes leadership roles at Pfizer and Merck, where David focused on process management and improvement, David Rodin exemplifies a deep commitment to advancing clinical research methodologies and patient engagement strategies. Academic credentials include a Master's and Bachelor's degree in Manufacturing Engineering from the University of Cambridge.
This person is not in any teams
This person is not in any offices
UpSite Clinical
Upsite Clinical has developed TrialPro, a budgeting tool designed to help clinical research sites negotiate fair rates, avoid unpaid work, and save time. Built by industry veterans with experience on both sponsor and site sides, TrialPro reads protocols and automatically generates budget grids, searches for unbudgeted work, and provides current FMV benchmarks specific to your site.